Urology News and Research

Latest Urology News and Research

Randomized trial shows patient-delivered partner treatment superior to partner referral in male urethritis

Ensuring that the sexual partners of patients diagnosed with urethritis are also treated remains a challenge since the traditional methods of partner referral are usually ineffective.

3 Apr 2006

Serum tumor markers predict extravesical disease in clinical stage T2 bladder cancer

Bladder cancer clinical staging is notoriously poor in patients with muscle invasive disease.

31 Mar 2006

Underutilization of partial nephrectomy for localized renal cell carcinoma in the U.S.

In the past, the gold standard for the treatment of localized renal tumors has been radical nephrectomy. Over time however, experience with nephron sparing surgery and, now, laparoscopic approaches have demonstrated oncologic equipoise and may provide for an improved quality of life for patients as compared to those undergoing radical nephrectomy for localized renal masses.

31 Mar 2006

Radical prostatectomy QoL outcomes can be obtained in single-surgeon practices

Most often urologists cite radical prostatectomy (RP) outcomes from large studies and high volume centers. However, these may not accurately reflect the outcomes of individual surgeons.

30 Mar 2006

Modification of O'Connor's technique for the treatment of vesico-vaginal fistula repair described

Vesicovaginal fistula (VVF) is a distressing disease with social, hygienic, and psychosexual consequences.

30 Mar 2006

Salvage radiation therapy for PSA recurrence following radical prostatectomy

Salvage radiation therapy to the prostatic fossa is often employed in patients with rising PSA after radical prostatectomy (RP). Interestingly, only 25% of men with rising PSA after RP have a positive prostatic fossa biopsy, yet 70% of men with a negative biopsy will have their PSA decline to undetectable levels following salvage external beam radiotherapy.

23 Mar 2006

Raloxifene shows potential benefits in treating prostate cancer

In a study to be published in the April, 2006 issue of the British Journal of Urology International, researchers at Cedars-Sinai Medical Center have shown that Raloxifene, a drug commonly used to treat osteoporosis, has a potential clinical benefit in treating men with prostate cancer.

23 Mar 2006

Delayed prostate cancer intervention in low risk patients may not decrease ultimate chance for cure

A contemporary discussion exists whether patients with low-risk prostate cancer (CaP) are being overtreated with local treatment modalities. This is due to a combination of the older population affected and the slow doubling time of CaP.

23 Mar 2006

Computerized tomography guided percutaneous renal cryoablation with the patient under conscious sedation

When an event occurs once, we have a tendency to look at it as a phenomenon, but when it occurs twice, it begins to enter the realm of accepted reality.

21 Mar 2006

Prostate cancer detected on repeat biopsies have more favorable tumor characteristics but similar recurrence rates

Prostate cancer (CaP) detected on repeat biopsy may reflect smaller volume tumors and less aggressive biological and clinical disease.

17 Mar 2006

Technique of urethroplasty for female stricture disease described

The incidence of obstruction from any cause occurs in approximately 2.7% to 8% of women presenting with lower urinary tract symptoms.

15 Mar 2006

Thrombocytosis: A clinical marker of tumor aggressiveness in renal cell carcinoma

Molecular and serum markers of prognosis in renal cell carcinoma have remained elusive. In large part, tumor (TNM) stage, Fuhrman grade, and patient performance status have stood the test of time as the most valuable factors in predicting patient outcome following surgery.

15 Mar 2006

Partial nephrectomy: urologists need to practice what we preach

There is no question in the urologic literature that partial nephrectomy (PN), particularly for renal masses ¡Ü 4cm, has demonstrated oncologic equipoise with radical nephrectomy (RN).

14 Mar 2006

Evidence grows about low number getting medical help for bladder problems

As few as four per cent of US adults with overactive bladders (OAB) seek medical treatment, despite the condition affecting an estimated 34 million Americans over the age of 18, according to research in the March issue of the UK-based urology journal BJU International.

13 Mar 2006

Renal and extrarenal predictors of nephrectomy from The National Trauma Data Bank reviewed

The management of renal trauma has become increasingly conservative with multiple series showing renal preservation after high grade injury.

13 Mar 2006

Therapy for metastatic renal cell carcinoma remains inadequate

The recent FDA approvals of the tyrosine kinase inhibitors sorafenib and sunitinib based on their activity in metastatic renal cell carcinoma have excited the medical oncology community

9 Mar 2006

Alfuzosin may improve double-J stent related symptoms

The first indwelling endoluminal ureteral stent was described over 30 years ago and has since become a routine and indispensable urologic tool. However, the side effects and patient morbidity associated with ureteral stents are not insignificant.

9 Mar 2006

Primary vesicoureteral reflux detected in neonates with a history of fetal renal pelvis dilatation

Fetal renal pelvis dilatation is a common abnormality, observed in 4.5% of pregnancies but surrounded by controversy regarding its significance. Working up renal pelvis dilation has become a standard of care regardless of the presence or absence of symptoms with vesicoureteral reflux (VUR) being one of the primary concerns.

8 Mar 2006

Is there any role for thalidomide as a monotherapy in the management of metastatic renal cell carcinoma?

Thalidomide remains an enigma in the treatment of metastatic renal cell carcinoma (RCC). Initial clinical trials suggested a benefit, but more recently, subsequent randomized trials studying thalidomide in combination with other agents such as interferon have demonstrated no added benefit.

8 Mar 2006

Is partial nephrectomy oncologically safe for tumors greater than 4cm?

Traditionally, nephron sparing surgery in the presence of a normal contralateral kidney is primarily advocated for tumors <= 4cm.

7 Mar 2006

Urology News and Research

Latest Urology News and Research

Randomized trial shows patient-delivered partner treatment superior to partner referral in male urethritis

Serum tumor markers predict extravesical disease in clinical stage T2 bladder cancer

Underutilization of partial nephrectomy for localized renal cell carcinoma in the U.S.

Radical prostatectomy QoL outcomes can be obtained in single-surgeon practices

Modification of O'Connor's technique for the treatment of vesico-vaginal fistula repair described

Salvage radiation therapy for PSA recurrence following radical prostatectomy

Raloxifene shows potential benefits in treating prostate cancer

Delayed prostate cancer intervention in low risk patients may not decrease ultimate chance for cure

Computerized tomography guided percutaneous renal cryoablation with the patient under conscious sedation

Prostate cancer detected on repeat biopsies have more favorable tumor characteristics but similar recurrence rates

Technique of urethroplasty for female stricture disease described

Thrombocytosis: A clinical marker of tumor aggressiveness in renal cell carcinoma

Partial nephrectomy: urologists need to practice what we preach

Evidence grows about low number getting medical help for bladder problems

Renal and extrarenal predictors of nephrectomy from The National Trauma Data Bank reviewed

Therapy for metastatic renal cell carcinoma remains inadequate

Alfuzosin may improve double-J stent related symptoms

Primary vesicoureteral reflux detected in neonates with a history of fetal renal pelvis dilatation

Is there any role for thalidomide as a monotherapy in the management of metastatic renal cell carcinoma?

Is partial nephrectomy oncologically safe for tumors greater than 4cm?

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Urology News and Research

Latest Urology News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in